At the end of the fiscal year 2021, the Tunisian company Unité de Fabrication de Médicaments (Unimed) recorded an increase of 24.68% in its net income. This increase is estimated at 24.68% compared to the net result of 2020.

The management of Unimed announced that the net result of the Tunisian company has experienced an increase of 24.68% compared to that of 2020. This announcement follows the meeting on April 08, 2022 of the Board of Directors of the company UNIMED, which examined the activity report of the company and decided on the results of the year.This announcement follows the meeting on April 8, 2022 of the Board of Directors of UNIMED, which examined the company's activity report and approved the financial statements for the year ending December 31, 2021. The net result thus came out at 8.703 million dinars (MDT) against 6.980 MDT for the financial year 2020. The turnover was located at 84.500 MDT against 91.045 MDT in 2020, a regression of 7.18%.

According to the management of UNIMED, this turnover is divided into 46% as national sales, or 39.220 MDT, against 67% under the year 2020, or 61.041 MDT, 54% as export sales, or 45.282 MDT.export, that is to say 45,282 MTD against 33% as of the financial year 2020, that is to say 30,004 MTD, thus recording an exceptional increase approaching 51% of the export turnover compared to the financial year 2020.